MARKET

XENE

XENE

Xenon Pharmaceut
NASDAQ
54.39
-1.61
-2.88%
After Hours: 53.00 -1.39 -2.56% 17:05 05/15 EDT
OPEN
55.64
PREV CLOSE
56.00
HIGH
55.73
LOW
54.31
VOLUME
610.34K
TURNOVER
--
52 WEEK HIGH
63.95
52 WEEK LOW
28.19
MARKET CAP
5.26B
P/E (TTM)
-11.5605
1D
5D
1M
3M
1Y
5Y
1D
Xenon Pharmaceuticals Is Maintained at Overweight by JP Morgan
Dow Jones · 4d ago
Xenon Pharmaceuticals Price Target Raised to $80.00/Share From $77.00 by JP Morgan
Dow Jones · 4d ago
JP Morgan Maintains Overweight on Xenon Pharmaceuticals, Raises Price Target to $80
Benzinga · 4d ago
Xenon Pharmaceuticals price target raised to $80 from $77 at JPMorgan
TipRanks · 4d ago
Weekly Report: what happened at XENE last week (0504-0508)?
Weekly Report · 5d ago
Xenon (XENE) Gets a Buy from Stifel Nicolaus
TipRanks · 5d ago
Xenon Pharmaceuticals price target raised to $69 from $68 at Wells Fargo
TipRanks · 6d ago
Wells Fargo Remains a Buy on Xenon (XENE)
TipRanks · 6d ago
More
About XENE
Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the advanced, clinically validated potassium channel modulator in late-stage clinical development for the treatment of multiple indications that include epilepsy, including focal onset seizures (FOS), and primary generalized tonic-clonic seizures (PGTCS), as well as neuropsychiatric disorders including major depressive disorder (MDD), and bipolar depression (BPD). The Company is evaluating multiple therapeutic candidates targeting Kv7, Nav1.7, and Nav1.1 across various indications.

Webull offers Xenon Pharmaceuticals Inc stock information, including NASDAQ: XENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XENE stock methods without spending real money on the virtual paper trading platform.